Breakthrough Lung Cancer Drug Earned FDA Nod 2015-10-05 10:07:43
The FDA has approved ‘breakthrough’ drug Keytruda (pembrolizumab) to fight lung cancer. Keytruda was tested on nearly non-small cell lung cancer patients in a largest study published till date using immunotherapy for lung cancer treatment. The FDA has granted the...
Keywords: lung cancer, FDA, FDA, KeytrudaRead More